A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial)Martha E. Teke, Kim A. Reiss, Areeba Saif et al.|Annals of Surgical Oncology|2022Cited by 6
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsCarrie E. Ryan, Heloisa P. Soares, Flavio G. Rocha et al.|Annals of Surgical Oncology|2022Cited by 3
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic GrowthSurajit Sinha, Geneti Gaga, Abir K. Panda et al.|Cancer Discovery|2025Cited by 2